Oncology

  1. Tagrisso (osimertinib)
    Tagrisso (osimertinib)
    by AstraZeneca AB
    for Lung Cancer
    €6,980.00
  2. Tecentriq (atezolizumab)
    Tecentriq (atezolizumab)
    by Roche Registration Limited
    for Urothelial Carcinoma, Lung Cancer
    €3,574.00
  3. Zejula (niraparib)
    Zejula (niraparib)
    by Tesaro UK Limited
    for Gynaecological Cancer
    €6,190.00
View as Grid List

Items 37-39 of 39

Page
per page
Set Descending Direction